Biopharma Cold Chain Logistics Market Expected to Reach US$26.8 Billion by 2027 | CAGR: 7.1%

Biopharma Cold Chain Logistics Market Expected to Reach US$26.8 Billion by 2027 | CAGR: 7.1%

The global biopharma cold chain logistics market size is expected to reach USD 26.8 Billion by 2027 according to a new study by Polaris Market Research. The Report “Biopharma Cold Chain Logistics Market Share, Size, Trends, Industry Analysis Report, By Component (Storage {Warehouse, and Refrigerated Container}, Transportation {Sea Freight Logistics, Air Freight Logistics, and Overland Logistics}, and Monitoring Components {Hardware [Sensors, RFID Devices, Telematics, and Networking Devices], and Software); By Regions; Segment Forecast, 2020 - 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.


The global market is anticipated to grow owing to the necessity of cold chain infrastructure in the supply chain network for the temperature sensitive vaccines and drugs, cost containment measures, and technology enabled services for real time monitoring. Moreover, government’s positive initiatives to reduce the wastage and enhancement of services at the local level is also expected to boost the investments in the concerned market.


The market is fragmented based on type, component, and region. In terms of type, the market is segmented into cold and non-cold. Based on component, the biopharma cold chain logistics market is bifurcated as storage, transportation, and monitoring components. Storage segment is further segmented as warehouse, and refrigerated container. Transportation is further segregated as sea freight logistics, air freight logistics, and overland logistics. Monitoring components is bifurcated as hardware and software.


Have Questions? Request a sample or make an Inquiry before buying this report by clicking the following link:


Segment Highlight

  • The storage segment accounted for the largest revenue share in 2019 and is expected to continue its dominance over the forecast period on account of the growing demand for temperature-sensitive pharmaceuticals.

  • Monitoring components segment is expected to witness significant growth over the projected period on account of the increasing need to maintain safety and integrity of the biopharmaceuticals

  • North America accounted for the largest revenue share in 2019 owing to the growing demand for biopharma cold chain logistics and presence of several market players operating in the U.S. and Canada

List of Key Players

  • Air Canada
  • DB Schenker
  • Kuehne+ Nagel
  • United Parcel Service of America, Inc.
  • Deutsche Post AG


Polaris Market Research has segmented the biopharma cold chain logistics market report on the basis of component and region

Biopharma Cold Chain Logistics, Component Outlook (Revenue - USD Million, 2016 – 2027)

  • Storage
    • Warehouse
    • Refrigerated Container
  • Transportation
    • Sea Freight Logistics
    • Air Freight Logistics
    • Overland Logistics
  • Monitoring Components
    • Hardware
      • Sensors
      • RFID Devices
      • Telematics
      • Networking Devices
    • Software

Biopharma Cold Chain Logistics, Regional Outlook (Revenue - USD Million, 2016 – 2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • Netherlands
    • Austria
  • Asia Pacific
    • China
    • India
    • Japan
    • Malaysia
    • South Korea
    • Indonesia
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa

License and Pricing

Purchase Report Sections

  • Regional analysis
  • Segmentation analysis
  • Industry outlook
  • Competitive landscape
Request for Discount Pricing